Plasma Concentrations of the Novel Peptide Apelin are Decreased in Patients with Chronic Heart Failure

Abstract

Plasma apelin concentrations are decreased in patients with CHF. The Apelin-APJ signaling pathway may be a potentially important mediator in the pathophysiological processes of heart failure and may therefore have potential therapeutic implications.